pharmaphorum6d
Lilly's Olumiant okayed in alopecia, with Pfizer, Concert in hot pursuit
Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug ... alopecia, although that is likely to diminish now that an FDA-approved option is available. The new ...
Medscape13h
Ritlecitinib Shows Long-Term Benefits in Alopecia Areata
A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...
Hosted on MSN1mon
Man with alopecia says he is being denied life changing drug – despite NHS approval
A man suffering alopecia says he is being denied a groundbreaking new drug – despite it being approved. The daily pill, called ritlecitinib or Litfulo, was green-lit for prescription on the NHS ...
WebMD29d
How Olumiant Works for Alopecia
New treatments like Olumiant offer hope for some people. This FDA-approved medicine works in unique ways to help improve hair regrowth. Olumiant provides people with alopecia areata another option ...
Pharmabiz1d
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...
Too Old to Operate6d
FDA Approved Dermatologic Therapies in 2024
The following is a summary of “A year in review: new treatments and expanded indications in dermatology in 2024,” published in the January 2025 issue of Dermatology by McGrath et al. In 2024, ...
HCW Biologics receives clearance of IND from FDA for HCW9302
HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...
The American Journal of Managed Care6d
Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA
Suzetrigine's approval highlights the ongoing need for effective non-opioid pain management solutions. Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years ...
USA Today6d
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
BioSpace6d
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...
The American Journal of Managed Care1d
Discussing Baricitinib for Alopecia Areata
Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...